Abstract
In the past decade, a number of case-control studies have been conducted to investigate the relationship between the ATP-binding cassette transporter A1 (ABCA1) R219K polymorphism and coronary heart disease (CHD). However, the results have been inconclusive. The purpose of the present study is to investigate whether this polymorphism confers significant susceptibility to CHD using a meta-analysis. PubMed, Embase and CNKI database were searched to get the genetic association studies. Then data were extracted. Pooled odds ratio (OR) and 95% confidence interval (CI) were calculated. Moreover, subgroup and sensitive analysis were performed. In total, 9,437 cases and 16,270 controls were involved in the meta-analysis. The K219 was significantly associated with CHD (OR = 0.80, 95% CI 0.69–0.92, P(Z) = 0.001). However, significant heterogeneity was present. Further subgroup analysis suggested ethnicity explained much heterogeneity. In Asians, K219 showed a strong protective effect and the pooled OR was 0.69 (95% CI 0.55–0.86 P(Z) = 0.0009). While in Caucasians the result was not significant (OR = 0.87, 95% CI 0.73–1.04, P(Z) = 0.12). In conclusion, our results indicate that the ABCA1 R219K polymorphism is a protective factor of CHD in Asians, but not in Caucasians.
Similar content being viewed by others
References
Yamada Y et al (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347(24):1916–1923
Shirai K et al (2009) Perceived level of life enjoyment and risks of cardiovascular disease incidence and mortality: the Japan public health center-based study. Circulation 120(11):956–963
Genest JJ Jr et al (1992) Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85(6):2025–2033
Assmann G, Nofer JR (2003) Atheroprotective effects of high-density lipoproteins. Annu Rev Med 54:321–341
Oram JF (2003) HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 23(5):720–727
Brunham LR, Singaraja RR, Hayden MR (2006) Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Annu Rev Nutr 26:105–129
Brooks-Wilson A et al (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22(4):336–345
Marcil M et al (1999) Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 354(9187):1341–1346
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
Zintzaras E, Hadjigeorgiou GM (2004) Association of paraoxonase 1 gene polymorphisms with risk of Parkinson’s disease: a meta-analysis. J Hum Genet 49(9):474–481
Brousseau ME et al (2001) Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis 154(3):607–611
Cenarro A et al (2003) A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia. J Med Genet 40(3):163–168
Evans D, Beil FU (2003) The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia. J Mol Med 81(4):264–270
Harada T et al (2003) A common Ile 823 Met variant of ATP-binding cassette transporter A1 gene (ABCA1) alters high density lipoprotein cholesterol level in Japanese population. Atherosclerosis 169(1):105–112
Tregouet DA et al (2004) In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler Thromb Vasc Biol 24(4):775–781
Zhao SP et al (2004) The study on ABCA1 R219K genetic variation in patients with coronary heart disease. Zhonghua Xin Xue Guan Bing Za Zhi 32(8):712–716
Whiting BM et al (2005) Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease. Am Heart J 150(2):243–250
Li Y et al (2005) Relationship between the R219K polymorphism of ATP-binding cassette transporter 1 gene and coronary heart disease. Yi Chuan 27(4):549–552
Sun P et al (2005) Study on the association of ABCA1 gene common variants with the risk of coronary atherosclerotic heart disease. Zhonghua Xin Xue Guan Bing Za Zhi 33(7):627–630
Woll PS et al (2005) Effect of two common polymorphisms in the ATP binding cassette transporter A1 gene on HDL-cholesterol concentration. Clin Chem 51(5):907–909
Martin M et al (2006) ABCA1 polymorphisms and prognosis after myocardial infarction in young patients. Int J Cardiol 110(2):267–268
Andrikovics H et al (2006) Decreased frequencies of ABCA1 polymorphisms R219K and V771M in Hungarian patients with cerebrovascular and cardiovascular diseases. Cerebrovasc Dis 21(4):254–259
Balcerzyk A, Zak I, Krauze J (2007) Synergistic effect between polymorphisms of PPARA and ABCA1 genes on the premature coronary artery disease. Acta Cardiol 62(3):233–238
Wang SH et al (2008) Geographical characteristics of single nucleotide polymorphism of candidate genes associated with coronary artery disease in Chinese Han population. Zhonghua Xin Xue Guan Bing Za Zhi 36(1):24–29
Frikke-Schmidt R et al (2008) Genetic variation in ABCA1 predicts ischemic heart disease in the general population. Arterioscler Thromb Vasc Biol 28(1):180–186
Porchay-Balderelli I et al (2009) Relationships between common polymorphisms of adenosine triphosphate-binding cassette transporter A1 and high-density lipoprotein cholesterol and coronary heart disease in a population with type 2 diabetes mellitus. Metabolism 58(1):74–79
Li J et al (2009) Effect of R219K polymorphism of the ABCA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease. Clin Exp Pharmacol Physiol 36(5–6):567–570
Doosti M et al (2010) The role of ATP-binding-cassette-transporter-A1 (ABCA1) gene polymorphism on coronary artery disease risk. Transl Res 155(4):185–190
Clee SM et al (2001) Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103(9):1198–1205
Singaraja RR et al (2002) Increased ABCA1 activity protects against atherosclerosis. J Clin Invest 110(1):35–42
Wang Y, Oram JF (2005) Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J Biol Chem 280(43):35896–35903
Acknowledgments
This work was supported by the 973 Program (2010CB529600, 2007CB947300), the 863 Program (2009AA022701), the National Nature Science Foundation of China (31071159), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the National Key Technology R&D Program (2006BAI05A09), the National Key Project for Investigational New Drugs 2008ZX09312-003, the Shanghai Leading Academic Discipline Project (B205).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Li, Y., Tang, K., Zhou, K. et al. Quantitative assessment of the effect of ABCA1 R219K polymorphism on the risk of coronary heart disease. Mol Biol Rep 39, 1809–1813 (2012). https://doi.org/10.1007/s11033-011-0922-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-011-0922-z